Long-term natalizumab treatment is associated with sustained improvements in quality of life in patients with multiple sclerosis.

Foley, John F; Nair, Kavita V; Vollmer, Timothy; Stephenson, Judith J; Niecko, Timothy; Agarwal, Sonalee S; Watson, Crystal.

Afiliação

Foley JF; Rocky Mountain Multiple Sclerosis Clinic, Salt Lake City, UT, USA.
Nair KV; Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Denver, Aurora, CO, USA.
Vollmer T; Department of Neurology, University of Colorado School of Medicine, Aurora, CO, USA.
Stephenson JJ; HealthCore, Inc., Wilmington, DE, USA.
Niecko T; Niecko Health Economics, Tierra Verde, FL, USA.
Agarwal SS; Biogen, Cambridge, MA, USA.
Watson C; Biogen, Cambridge, MA, USA.

Patient Prefer Adherence ; 11: 1035-1048, 2017.

Article em En | MEDLINE | ID: mdl-28670113